SLIDESHOW: The 25 Most Shorted Stocks of the Nasdaq 100

(1) BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) — 11.21 Days to Cover

BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome; Kuvan (sapropterin dihydrochloride) for phenylketonuria; Naglazyme (galsulfase) for Mucopolysaccharidosis VI; and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A.

BMRN — Key Stats (updated Friday, December 7, 10:40 AM)

Name:  BioMarin Pharmaceutical Inc. Website:  www.biomarin.com Sector:  Drugs & Pharmaceuticals Number of ETFs Holding BMRN:  45 (see which ones) Total Market Value Held by ETFs:  $740,419,841 Total Market Capitalization:  $16,683,000,000 % of Market Cap. Held by ETFs:  4.44%

Open the Dividend Channel BMRN Page (in a new window) »

Featured Slideshows

Warren Buffett Dividend Stocks Dividend Growth Stocks: 25 Aristocrats Future Dividend Aristocrats: Close Contenders The Top 10 DividendRank'ed Stocks Decades of Increasing Payments: 25 S.A.F.E. Dividend Stocks The DividendRank Top 25 The Top 10 DividendRank'ed DJIA Components Feel-Good Income: 25 Socially Responsible Dividend Stocks The Top 10 DividendRank'ed Dow Transports Components The Top 10 DividendRank'ed Dow Utilities Components The Top 10 DividendRank'ed Nasdaq 100 Components 10 Stocks Going Ex-Dividend 10 Oversold Dividend Stocks 10 High Yield Baby Bonds 10 Stocks Where Yields Got More Juicy 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did Top Ranked Dividend Stocks With Insider Buying Best Dividend Stocks Analysts Like in the S&P Best Dividend Paying Stocks Analysts Like in the Dow 10 Cheap Dividend Stocks Under $10 10 Low Priced Dividend Stocks Under $5 Broker Darlings: Top 15 Analyst Picks of the Dow Top 25 Broker Analyst Picks of the S&P 500 Forgotten S&P 500 Giants: Analysts' Current Least Favorites 10 ETFs With Stocks That Insiders Are Buying 25 Dividend Giants Widely Held By ETFs 10 Energy Stocks You Can Buy Cheaper Than Insiders Did 10 Metals Stocks You Can Buy Cheaper Than Insiders Did 10 Oversold Metals Stocks 10 Must-Know High-Yield REITs 10 Top DividendRank'ed Financials 10 Top DividendRank'ed Metals Stocks 10 Oversold Energy Stocks 10 Top DividendRank'ed Energy Stocks 10 Top DividendRank'ed Utility Stocks 10 Stocks Crossing Below Book Value 10 Stocks Crossing Above Their 200 Day Moving Average 10 Stocks Crossing Below Their 200 Day Moving Average 10 Dividend Stocks Crossing Above Their 200 DMA 10 Dividend Stocks Crossing Below Their 200 DMA The 10 Biggest ETFs The 10 Best ETF Performers The 10 Worst ETF Performers 10 ETFs With Notable Inflows 10 ETFs With Notable Outflows The Ten Most Shorted Stocks of the Dow The 25 Most Shorted Stocks of the Nasdaq 100 The 25 Most Shorted Stocks of the S&P 500 Top 10 Analyst Rated Consumer Stocks Top 10 Analyst Rated Dividend Stocks Top 10 Analyst Rated Energy Stocks Warren Buffett Energy Stocks Top 10 Analyst Rated Financial Stocks Warren Buffett Bank Stocks Top 10 Analyst Rated Healthcare Stocks Top 10 Analyst Rated REIT Stocks Top 10 Analyst Rated Technology Stocks Warren Buffett Technology Stocks The Top 10 DividendRank'ed Canadian Stocks The DividendRank Canada Top 25 10 Canadian Stocks Going Ex-Dividend 10 Oversold Canadian Stocks 10 Canadian Stocks Where Yields Got More Juicy 10 Must-Know High-Yield Canadian Real Estate Stocks 10 Top DividendRank'ed Canadian Financials 10 Must-Know High-Yield Canadian Energy Stocks 10 Canadian Stocks Crossing Below Book Value 10 Canadian Stocks Crossing Above Their 200 Day Moving Avg 10 Canadian Stocks Crossing Below Their 200 Day Moving Avg Stock market game

Advertising Opportunities on Dividend Channel